# A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

> **NCT07347548** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Grünenthal GmbH** · enrollment: 24 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy (DMD)

## Interventions

- **DRUG:** GRT6019

## Key facts

- **NCT ID:** NCT07347548
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07347548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07347548, "A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07347548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*